Survival after stroke - The impact of CHADS2 score and atrial fibrillation

被引:102
|
作者
Henriksson, Karin M. [1 ]
Farahmand, Bahman [2 ]
Johansson, Saga [3 ]
Asberg, Signild [4 ]
Terent, Andreas [4 ]
Edvardsson, Nils [3 ]
机构
[1] Lund Univ, Dept Lab Med, S-22185 Lund, Sweden
[2] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden
[3] Sahlgrens Univ Hosp, Sahlgrenska Acad, Gothenburg, Sweden
[4] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden
关键词
Stroke; Atrial fibrillation; CHADS(2) score; Mortality; Risk factor; ANTITHROMBOTIC THERAPY; RISK STRATIFICATION; CRYPTOGENIC STROKE; PREDICTING STROKE; SCHEMES; ANTICOAGULATION; CLASSIFICATION; ASPIRIN; TRIALS;
D O I
10.1016/j.ijcard.2008.11.122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study examined all-cause mortality in stroke patients with and without documented atrial fibrillation (AF), and the impact of CHADS(2) score. Design: A cohort of 105,074 patients, 31,821 (30.3%) with and 73,253 (69.7%) without documented AF, was studied. These patients were registered in the Swedish Stroke Registry during the years 2001-2005. Mortality data were retrieved from the Swedish Cause of Death Register. CHADS(2) score prior to stroke were assessed using the Swedish National Discharge Register. Results: The age and sex adjusted relative risk (RR) of death was 1.46 (1.43-1.49) for AF vs non-AF patients. High age (>= 75 years) tripled the risk of death and was the single most important predictor, followed by congestive heart failure, previous stroke and diabetes. Less than half of the AF patients with a CHADS(2) score of 1-6 survived more than 5 years, whereas AF patients with a CHADS(2) score of 0 had a 73% chance of survival. In patients with AF, the relative risk of death was 6.05 (CI: 2.26-6.95); in subjects with the highest vs the lowest CHADS(2) score; the corresponding RR for non-AF patients was 7.93 (CI: 7.01-8.97). Conclusions: The CHADS(2) score seems to have an impact on all-cause mortality after stroke. The CHADS(2A\) score can give valuable insight for other outcome variables apart from having had an ischemic stroke and can be applied to patients with different risk factor profiles, e. g. with a previous known cardiovascular disease but without known AF. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [21] Oral Anticoagulation in Nonvalvular Atrial Fibrillation in Clinical Practice: Impact of CHADS2 Score on Outcome
    Ruiz Ortiz, Martin
    Romo, Elias
    Mesa, Dolores
    Delgado, Monica
    Anguita, Manuel
    Castillo, Juan C.
    Arizon, Jose M.
    Suarez de Lezo, Jose
    CARDIOLOGY, 2010, 115 (03) : 200 - 204
  • [22] A nomogram based on CHADS2 score for predicting atrial fibrillation recurrence after cryoballoon ablation
    Liu, Yu
    Tian, Youpeng
    Fan, Jinqi
    Xu, Yanping
    Chen, Yun-Lin
    Yin, Yuehui
    JOURNAL OF CARDIAC SURGERY, 2022, 37 (12) : 4589 - 4597
  • [23] Role of the combined CHADS2 score and echocardiographic abnormalities in predicting stroke in patients with paroxysmal atrial fibrillation
    Gupta, Nishant
    Haft, Jacob I.
    Bajaj, Sharad
    Samuel, Anish
    Parikh, Rupen
    Pandya, Dipak
    Shamoon, Fayez
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (09) : 1242 - 1245
  • [24] Impact Of CHADS2 Score On Severity And Outcome Of Ischemic Stroke
    Kim, Dohoung
    Chung, Jong-Won
    Kim, Chi Kyung
    Ryu, Wi-Sun
    Park, Eun-Sun
    Lee, Seung-Hoon
    STROKE, 2011, 42 (03) : E192 - E192
  • [25] Assessment of global left atrial strain predicts CHADS2 score in atrial fibrillation
    Saha, S. K.
    Anderson, P. L.
    Caracciolo, G.
    Kiotsekoglou, A.
    Govind, S.
    Wilansky, S.
    Sengupta, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 112 - 112
  • [26] Ankle-brachial index according to CHADS2 score in stroke patients with nonvalvular atrial fibrillation
    Do, Y.
    Kwak, J. H.
    CEREBROVASCULAR DISEASES, 2015, 39 : 60 - 60
  • [27] Are family physicians using the CHADS2 score? Is it useful for assessing risk of stroke in patients with atrial fibrillation?
    Klein, Douglas
    Levine, Max
    CANADIAN FAMILY PHYSICIAN, 2011, 57 (08) : E305 - E309
  • [28] COST EFFECTIVENESS OF RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS FOR TTR AND CHADS2 SCORE IN LITHUANIA
    Kockaya, G.
    Aidietiene, S.
    Ergin, Oguzhan G.
    Okcun, S.
    Kurnaz, M.
    VALUE IN HEALTH, 2019, 22 : S558 - S559
  • [29] COST EFFECTIVENESS OF RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS FOR TTR AND CHADS2 SCORE IN TURKEY
    Ergin, Oguzhan G.
    Kockaya, G.
    Caliskan, Z.
    Okcun, S.
    Kurnaz, M.
    Buyuktuna, N.
    Buyukisik, T.
    Saylan, M.
    VALUE IN HEALTH, 2019, 22 : S552 - S552
  • [30] Impact of CHADS2 Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke
    Kim, Dohoung
    Chung, Jong-Won
    Kim, Chi Kyung
    Ryu, Wi-Sun
    Park, Eun-Sun
    Lee, Seung-Hoon
    Yoon, Byung-Woo
    JOURNAL OF CLINICAL NEUROLOGY, 2012, 8 (04): : 251 - 258